Latest news with #MohammedSaeedAlRaqbani
Hi Dubai
30-04-2025
- Business
- Hi Dubai
Dubai Investments Drives Inclusive, Low-Carbon Growth in 2024 ESG Report
Dubai Investments, the diversified investment company listed on the Dubai Financial Market, has released its 2024 ESG Report under the theme 'Resilient Futures Advancing Sustainability Through Innovation and Collaboration.' The report highlights measurable progress across clean energy, operational efficiency, workforce development, and community initiatives, with expanded coverage across 12 wholly owned subsidiaries. The 2024 ESG Report affirms Dubai Investments' alignment with international and national standards, including GRI, DFM ESG Indicators, and the UAE's sustainability vision. As the Group looks ahead, its strategy remains rooted in transparency, measurable impact, and long-term resilience, driven by innovation and collaborative action. At the foundation of this progress lies strong corporate governance, which continues to guide our sustainability agenda. With oversight from an experienced and diverse Board of Directors, the Group is embedding ESG principles at every level of decision-making. In 2024, Dubai Investments reinforced its commitment to ethical conduct, risk oversight, and regulatory compliance, ensuring that resilience, transparency, and accountability remain central to the Group's long-term strategy. said Mohammed Saeed Al Raqbani, Head of Sustainability Committee at Dubai Investments Accelerating its transition toward a low-carbon future, Dubai Investments commissioned a 1.2 MW rooftop solar system at the Ritaj community, now supplying nearly 30% of its energy needs through renewables. Emirates Float Glass improved energy efficiency through targeted operational enhancements, while Emirates Extrusion Factory achieved 100% aluminium scrap reuse and implemented eco-efficient coating technologies. Group-wide efforts in water conservation advanced, with subsidiaries expanding reuse and treatment systems to reduce consumption and protect local ecosystems. Human capital development remained a core ESG pillar in 2024. Over 2,700 employees participated in 9,600+ hours of training, spanning leadership, technical, and sustainability topics. Career development reviews achieved 100% coverage, reinforcing a culture of continuous growth. The Group advanced its Emiratisation agenda and also maintained full occupational health and safety coverage with zero fatalities reported. Community engagement also saw momentum through initiatives like the Green Run, school supply campaigns, and fertility awareness drives. Click here to view the full report News Source: MSL Group
Zawya
30-04-2025
- Business
- Zawya
Dubai Investments drives inclusive, low-carbon growth in 2024 ESG Report
Dubai, UAE – Dubai Investments, the diversified investment company listed on the Dubai Financial Market, has released its 2024 ESG Report under the theme 'Resilient Futures – Advancing Sustainability Through Innovation and Collaboration.' The report highlights measurable progress across clean energy, operational efficiency, workforce development, and community initiatives, with expanded coverage across 12 wholly owned subsidiaries. The 2024 ESG Report affirms Dubai Investments' alignment with international and national standards, including GRI, DFM ESG Indicators, and the UAE's sustainability vision. As the Group looks ahead, its strategy remains rooted in transparency, measurable impact, and long-term resilience—driven by innovation and collaborative action. 'At the foundation of this progress lies strong corporate governance, which continues to guide our sustainability agenda,' said Mohammed Saeed Al Raqbani, Head of Sustainability Committee at Dubai Investments. 'With oversight from an experienced and diverse Board of Directors, the Group is embedding ESG principles at every level of decision-making. In 2024, Dubai Investments reinforced its commitment to ethical conduct, risk oversight, and regulatory compliance—ensuring that resilience, transparency, and accountability remain central to the Group's long-term strategy.' Accelerating its transition toward a low-carbon future, Dubai Investments commissioned a 1.2 MW rooftop solar system at the Ritaj community, now supplying nearly 30% of its energy needs through renewables. Emirates Float Glass improved energy efficiency through targeted operational enhancements, while Emirates Extrusion Factory achieved 100% aluminium scrap reuse and implemented eco-efficient coating technologies. Group-wide efforts in water conservation advanced, with subsidiaries expanding reuse and treatment systems to reduce consumption and protect local ecosystems. Human capital development remained a core ESG pillar in 2024. Over 2,700 employees participated in 9,600+ hours of training, spanning leadership, technical, and sustainability topics. Career development reviews achieved 100% coverage, reinforcing a culture of continuous growth. The Group advanced its Emiratisation agenda and also maintained full occupational health and safety coverage with zero fatalities reported. Community engagement also saw momentum through initiatives like the Green Run, school supply campaigns, and fertility awareness drives. To explore the full report, visit: Dubai Investments PJSC Dubai Investments is a publicly listed UAE based multi-asset investment Group, managing a diverse portfolio of businesses, generating sustainable financial returns to its shareholders. Established in 1995, Dubai Investments is one of the leading investments Group in the UAE, initiating new businesses and partnering with dynamic entities, creating strategic investment opportunities across the region. With 15,956 shareholders, a paid-up capital of AED 4.25 billion and total assets worth more than AED 22 billion, the Group applies insight and experience to expand and be a reliable growth driver for businesses within sectors like real estate, manufacturing, healthcare, education, investments and services. The Group's diverse portfolio consists of wholly and partly owned companies and reflects the Company's continued focus on business diversification to drive growth in line with evolving industry trends. Focused on leveraging strengths with an interest in establishing existing and new business opportunities with a long-term, strategic and creative approach and with an emphasis on sustainable returns and capital growth, Dubai Investments collaborates on investment strategies meeting the changing needs of the economy and the societies in which it operates. Complementing the strategic objectives and creating value for stakeholders, the Group pursues growth through mergers and acquisitions and business expansions. To know more visit - .
Hi Dubai
08-04-2025
- Business
- Hi Dubai
Globalpharma and ZIM Labs Join Forces to Bring EU-Certified Oral Dispersible Film Technology to the UAE
Globalpharma, a leading UAE-based pharmaceutical manufacturer and a subsidiary of Dubai Investments PJSC, has partnered with India's ZIM Laboratories to introduce EU-certified Oral Dispersible Film (ODF) technology to the region. The collaboration was officially announced during AIM Congress 2025, held from April 7–9 in Dubai. ODF technology, recognised for its patient-friendly format—thin, fast-dissolving strips that require no water—offers an ideal solution for children, the elderly, and individuals with swallowing difficulties. ZIM Labs' proprietary formulation is EU-GMP certified, meeting rigorous international standards for quality and safety. The agreement was signed in the presence of Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade and Chairman of the Emirates Drug Establishment. Signatories included Mohammed Saeed Al Raqbani, General Manager of Dubai Investments Industries and Board Director at Globalpharma, and Zulfiquar Kamal, Promoter & Finance Director at ZIM Labs. 'This partnership is a transformative step for Globalpharma,' said Al Raqbani. 'It reinforces our vision to drive healthcare innovation and position the UAE as a regional leader in advanced drug manufacturing.' Dr. Basem Al-Barahmeh, General Manager of Globalpharma, added, 'By localising ODF production, we're not only enhancing treatment accessibility but also setting a new regional standard in pharmaceutical manufacturing.' ZIM Labs' Kamal echoed the sentiment, calling the move a 'milestone in expanding access to next-gen drug delivery systems across the GCC.' Globalpharma's dedicated ODF production line already includes ten products in development, reinforcing the UAE's growing role in shaping global pharma innovation. News Source: MSL
Zawya
08-04-2025
- Business
- Zawya
Globalpharma partners with ZIM Laboratories to revolutionize oral drug technology in the UAE
Dubai, UAE - Globalpharma, the UAE's leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, has collaborated with India's ZIM Laboratories to bring EU-certified Oral Dispersible Film (ODF) technology to its growing portfolio. This innovative drug technology has already received EU Good Manufacturing Practice (EU-GMP) certification, ensuring it meets the highest international quality and safety standards. The agreement, unveiled at AIM Congress 2025 (7-9 April), underscores the UAE's growing influence in global pharmaceutical innovation and its commitment to cutting-edge healthcare solutions. The signing ceremony, witnessed by H.E. Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade and Chairman of the Board of Emirates Drug Establishment (EDE), was signed by Mohammed Saeed Al Raqbani, General Manager of Dubai Investments Industries and Masharie and Board Director at Globalpharma and Zulfiquar Kamal, Promoter & Finance Director at ZIM Labs in the presence of Dr. Mariam Galadari, Board Member, Globalpharma. Reinforcing Globalpharma's thought leadership at AIM Congress 2025, Dr. Basem Al-Barahmeh, Globalpharma's General Manager, delivered a compelling keynote on the UAE's emergence as a pharmaceutical manufacturing powerhouse. Additionally, Dr. Geeta Gujaran, Globalpharma's Site Head, shared expert insights on the "Leaders' Panel: Manufacturing 2030 — Key Trends Shaping the Industry," highlighting key innovations shaping the sector. Commenting on the collaboration, Mohammed Saeed Al Raqbani stated: 'This partnership with ZIM Labs is a transformative step for Globalpharma. By bringing EU-certified ODF technology to the UAE, we are strengthening the region's pharmaceutical capabilities and advancing patient-centric treatment options. This move aligns with our vision to invest in innovations that elevate regional healthcare standards while positioning the UAE as a leader in advanced drug manufacturing.' ODFs represent a breakthrough in the drug industry, offering thin, fast-dissolving strips that melt in the mouth without water—ideal for children, elderly patients, and those with swallowing difficulties. ZIM Labs' proprietary technology enables the seamless incorporation of medications into these stable, rapid-acting films, enhancing patient compliance and treatment efficacy. Globalpharma's General Manager, Dr. Basem Al-Barahmeh, emphasized the significance of this development: 'By acquiring and localizing ODF production within UAE facility, Globalpharma is not only introducing innovative treatments but also setting a benchmark for pharmaceutical manufacturing in the region. Our dedicated production line, with a growing portfolio of ten ODF products, puts us at the forefront of this technology in the Middle East. This step reinforces the UAE's role as a key player in global pharma advancements.' Zulfiquar Kamal, Promoter & Finance Director at ZIM Labs, also highlighted the collaboration's impact: 'This technology transfer with globalpharma is a significant milestone in our mission to expand access to patient-friendly drug delivery systems around the world. Our EU-GMP certified ODF technology, combined with Globalpharma's regional reach and manufacturing strength, will set a new benchmark for pharmaceutical innovation in the GCC." ZIM Laboratories Limited (the Company) is a research-driven pharmaceutical company that develops, manufactures, and supplies differentiated generic products in oral solid dosage forms across key therapeutic segments. The Company has state-of-the-art in-house R&D capabilities to offer innovative drug delivery solutions using proprietary technology platforms, aiming to enhance patient convenience and treatment adherence. ZIM Laboratories Limited is listed on the National Stock Exchange of India Limited (NSE) and BSE Limited. About Globalpharma Globalpharma is a wholly owned subsidiary of Dubai Investments PJSC. Established in 1998, Globalpharma is currently a market leader in key generic pharma segments with a strong regional footprint. Globalpharma started its operations in the UAE in 2003 and expanded its growth in 2008 with product line extensions and new product launches across 14 countries in the GCC and select African markets. Currently Globalpharma has two Manufacturing plants, A state of the art Beta-Lactam Penicillin Manufacturing plant providing the Amoxicillin & AmoxiClav brands in the larger MENA region. Additionally, catering to the Lifestyle disease segments, is a General Medicine Manufacturing Plant with a variety of Liquid & Oral Solid Dose capabilities. About ZIM Labs Established in 1989, ZIM Labs specializes in the development, manufacturing, and supply of differentiated generic products in oral solid dosage forms. Additionally, ZIM Labs offers Pre-Formulation Intermediates (PFI) and Finished Formulations (FF) across key therapeutic segments for Rest of the World (RoW) markets. With a focus on global expansion, the company has diversified their offerings across two key verticals: Pharmaceuticals and Nutraceuticals.
Hi Dubai
13-02-2025
- Business
- Hi Dubai
Dubai Investments Signs Two Key MOUs as Part of MoIAT's Regional Industrial Partnership
Dubai Investments, a leading diversified investment company listed on the Dubai Financial Market (DFM), has announced that its subsidiaries, GlobalPharma and Emirates Float Glass (EFG), have signed key Memorandums of Understanding (MOUs) during the 5th Higher Committee Meeting of the Integrated Industrial Partnership for Sustainable Economic Development in Doha, Qatar. The agreements, supported by the UAE's Ministry of Industry and Advanced Technology (MoIAT), aim to accelerate industrial growth, strengthen regional cooperation, and drive sustainable development across critical sectors. The high-profile event brought together industry ministers from the UAE, Egypt, Jordan, Bahrain, Morocco, Qatar, and Turkey, marking a significant step in expanding cross-border collaboration and investment. Mohammed Saeed Al Raqbani, General Manager of Dubai Investments Industries and Masharie, highlighted the importance of these agreements, stating, 'The signing of these MOUs reflects Dubai Investments' commitment to fostering industrial integration, strengthening regional supply chains, and driving sustainable economic development. By leveraging the expertise of our subsidiaries, we are contributing to the region's industrial growth and enhancing the competitive edge of our partners.' As part of the pharmaceutical sector's expansion, GlobalPharma, a key generics manufacturer under Dubai Investments, signed an MOU with Morocco's Zenith Pharma. The agreement, backed by an investment exceeding $50 million, focuses on technology transfer, licensing, and local production of critical medications, including injectable biologics, cholesterol treatments, and diabetes solutions. GlobalPharma was also recognized by attending ministers for its contributions to pharmaceutical research and development within the partnership. In the glass manufacturing sector, Emirates Float Glass (EFG) signed an MOU with a regional manufacturer in Bahrain to supply high-quality float glass for glass and silver mirror production. The agreement strengthens industrial integration between the UAE and Bahrain, ensuring a steady supply of raw materials and enhancing manufacturing efficiency. These strategic collaborations reinforce Dubai Investments' role in advancing regional industrial self-sufficiency and sustainable economic development. News Source: MSL
